Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and...

Source: BMC Urology - October 21, 2019 Category: Urology & Nephrology Authors: C. Senger, A. Conti, A. Kluge, D. Pasemann, M. Kufeld, G. Acker, M. Lukas, A. Gr ün, G. Kalinauskaite, V. Budach, J. Waiser and C. Stromberger Tags: Research article Source Type: research